Cote G - Search Results

1

miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo.

Duan Z, Gao Y, Shen J, Choy E, Cote G, Harmon D, Bernstein K, Lozano-Calderon S, Mankin H, Hornicek FJ. Duan Z, et al. Among authors: cote g. Mol Oncol. 2017 Feb;11(2):151-166. doi: 10.1002/1878-0261.12015. Epub 2016 Oct 24. Mol Oncol. 2017. PMID: 28145098 Free PMC article. Clinical Trial.

2

Role of epigenetic modulation for the treatment of sarcoma.

Cote GM, Choy E. Cote GM, et al. Curr Treat Options Oncol. 2013 Sep;14(3):454-64. doi: 10.1007/s11864-013-0239-3. Curr Treat Options Oncol. 2013. PMID: 23749746

3

Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cells.

Jia B, Choy E, Cote G, Harmon D, Ye S, Kan Q, Mankin H, Hornicek F, Duan Z. Jia B, et al. Among authors: cote g. Cancer Lett. 2014 Jan 1;342(1):104-12. doi: 10.1016/j.canlet.2013.08.040. Epub 2013 Sep 2. Cancer Lett. 2014. PMID: 24007862 Free PMC article.

4

Update in treatment and targets in Ewing sarcoma.

Cote GM, Choy E. Cote GM, et al. Hematol Oncol Clin North Am. 2013 Oct;27(5):1007-19. doi: 10.1016/j.hoc.2013.07.001. Epub 2013 Aug 3. Hematol Oncol Clin North Am. 2013. PMID: 24093173 Review.

5

Prognostic significance of miRNA-1 (miR-1) expression in patients with chordoma.

Duan Z, Shen J, Yang X, Yang P, Osaka E, Choy E, Cote G, Harmon D, Zhang Y, Nielsen GP, Spentzos D, Mankin H, Hornicek F. Duan Z, et al. Among authors: cote g. J Orthop Res. 2014 May;32(5):695-701. doi: 10.1002/jor.22589. Epub 2014 Feb 5. J Orthop Res. 2014. PMID: 24501096 Free PMC article.

6

Synergistic effects of targeted PI3K signaling inhibition and chemotherapy in liposarcoma.

Guo S, Lopez-Marquez H, Fan KC, Choy E, Cote G, Harmon D, Nielsen GP, Yang C, Zhang C, Mankin H, Hornicek FJ, Borger DR, Duan Z. Guo S, et al. Among authors: cote g. PLoS One. 2014 Apr 2;9(4):e93996. doi: 10.1371/journal.pone.0093996. eCollection 2014. PLoS One. 2014. PMID: 24695632 Free PMC article.

7

Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925.

Yang X, Yang P, Shen J, Osaka E, Choy E, Cote G, Harmon D, Zhang Z, Mankin H, Hornicek FJ, Duan Z. Yang X, et al. Among authors: cote g. Br J Cancer. 2014 Jun 10;110(12):2896-904. doi: 10.1038/bjc.2014.254. Epub 2014 May 22. Br J Cancer. 2014. PMID: 24853187 Free PMC article.

8

Programmed cell death ligand 1 expression in osteosarcoma.

Shen JK, Cote GM, Choy E, Yang P, Harmon D, Schwab J, Nielsen GP, Chebib I, Ferrone S, Wang X, Wang Y, Mankin H, Hornicek FJ, Duan Z. Shen JK, et al. Among authors: cote gm. Cancer Immunol Res. 2014 Jul;2(7):690-698. doi: 10.1158/2326-6066.CIR-13-0224. Epub 2014 Apr 21. Cancer Immunol Res. 2014. PMID: 24866169 Free PMC article.

9

Genotyping cancer-associated genes in chordoma identifies mutations in oncogenes and areas of chromosomal loss involving CDKN2A, PTEN, and SMARCB1.

Choy E, MacConaill LE, Cote GM, Le LP, Shen JK, Nielsen GP, Iafrate AJ, Garraway LA, Hornicek FJ, Duan Z. Choy E, et al. PLoS One. 2014 Jul 1;9(7):e101283. doi: 10.1371/journal.pone.0101283. eCollection 2014. PLoS One. 2014. PMID: 24983247 Free PMC article.

10

A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells.

Duan Z, Zhang J, Ye S, Shen J, Choy E, Cote G, Harmon D, Mankin H, Hua Y, Zhang Y, Gray NS, Hornicek FJ. Duan Z, et al. Among authors: cote g. BMC Cancer. 2014 Sep 19;14:681. doi: 10.1186/1471-2407-14-681. BMC Cancer. 2014. PMID: 25236161 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,022 results

Search Page

Filters